Daily Equity Reports 25 March 2019

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 25 THMARCH 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! INDIANEQUITYBENCHMARK- Benchmarkindicesended lowerbutoffday'slowonFridaywithNiftyfinishedbelow 11,500level.Atclose,theSensexwasdown222.14pointsat NIFTY 38164.61,whileNiftywasdown64.10pointsat11456.90. CLOSE PREVIOUS About 1009 shares have advanced, 1665 shares declined, NIKKEI and143sharesareunchanged.NTPC,L&T,AsianPaints,JSW SteelandHindalcoIndustriesweretopgainersontheNifty, whileloserswereBhartiInfratel,BPCL,TataMotors,HPCL 2186.95 2184.88 and Reliance Industries. Except infra all other sectoral indicesended in redledbyNifty PSU bank,auto,energy, CLOSE CHANGE (%) pharma,metalandIT.BSEMidcapfell0.60percent,while CNX 100 Smallcapindexfell0.40percent. GLOBALFACE S&P CNX 500 9500.05 4897.45 ! CNX 200 5979.95 AsianMarket- Asianmarketsfinishedhighertodaywith sharesin HongKongleadingtheregion.TheHangSengisup BANK NIFTY 0.14%whileChina'sShanghaiCompositeisup0.09%and Japan'sNikkei225isup0.09%. TOP GAINERS CLOSE CHANGE (%) ! U.S.Market– NorthandSouthAmericanmarketsfinished mixedas ofthemostrecentclosingprices.TheS&P500 3.75 1.76 gained1.09%andtheIPCrose0.22%.TheBovespalost 1.34%. ASIANPAINT 1.03 ! Europeanmarkets– Europeanmarketsarelowertoday 285.00 0.96 TOP LOSERS whileLondon'sFTSE100isoff0.86%andGermany'sDAXis CLOSE CHANGE (%) lowerby0.57%. 377.00 315.30 175.30 268.20 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY BUY ON DIPS SCRIPT CLOSE (%) 3.75 NTPC PIVOT POINTS 0.82 S3 11211 S2 11349 R1 11541 R2 11626 R3 11764 INFY 11403 11488 0.80 S1-11304 S2-11229 R1-11621 R2-11763 0.72 TATASTEEL CLOSE (%) -3.12 BPCL -2.36 IOC -2.21 -2.05 ZEEL NET BUY (CR.) NET SELL (CR) STRATEGY BUY ON DIPS 7252.39 BULLISH PIVOT POINTS P 29774 DII 3319.03 S1 29457 R1 29977 R2 R3 30814 28734 29254 30294 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 9 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! ! CadilasaysnoobservationbyUSFDA onAhmedabadR&Dfacility TataPowerSEDbagscontractfrom MinistryofDefenceworthRs1,200cr TataPowerStrategicEngineeringDivision(TataPower SED)announcedthesigningofanimportantdealwith theMinistry ofDefence,GovernmentofIndia,tosupply 23ship-borne3DAirSurveillanceRadarstotheIndian Navy over the next 10 years. The contract, estimated value is about Rs1200cr, was signed under the Buy & Make (India) category of the Defence Procurement Procedure(DPP) 2013 that will beoffering the Indian Navyaprovensolution,withaproductionarrangement inIndiaunderTransferofTechnology(ToT)andthereby furthering substantive self-reliance for Indias defence requirements. SharesofCadilaHealthcareslipped2%inthelasthourof the trading session on the BSE. "USFDA inspected the PharmaceuticalTechnologyCentre(PTC),thecompany's state-of-the-art R&D facility located at Ahmedabad, dedicatedtonewproduct development ofvarious niche dosageformsincludingsolidoral,parenteral,pulmonary, oncology, ointment & creams and transdermal, from March18toMarch22,2019,"thecompanysaidintheBSE filing.Attheendoftheinspection, noobservations(483) havebeenissued,thecompanyadded. ! ZydusgetsfinalnodfromUSFDAfor LurasidoneHydrochloridetablets Zydus Cadila has received the final approval from the USFDAtomarketLurasidoneHydrochlorideTabletsUSP (USRLD- LatudaTablets),inthestrengthsof20mg,40 mg,60mg,80mgand120mg.Itwillbemanufacturedat thegroupsmanufacturingfacilityatSEZ,Ahmedabad,as per BSE filing added. The medication is used to treat certain mental/mood disorders such as schizophrenia, depressionassociatedwithbipolardisorder.Itmayalso help to decrease hallucinations (hearing/seeing things thatarenotthere). ! LupinlaunchesgenericLevothyroxineSodium TabletsUSP PharmamajorLupinLimited(Lupin)announcedthelaunchof LevothyroxineSodiumTabletsUSP,havingreceivedapproval fromtheUSFDAearlier.LupinsLevothyroxineSodiumTablets USP,isthegenericequivalentofAbbVie,IncsSynthroidTablets, asperBSEfiling.Itisindicatedfor:Hypothyroidism:As replacement therapy in primary (thyroidal), secondary (pituitary),andtertiary(hypothalamic)congenitaloracquired hypothyroidism Pituitary Thyrotropin (Thyroid-Stimulating Hormone,TSH)Suppression:Asanadjuncttosurgeryand radioiodinetherapyinthemanagement. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NAME OF THE STOCK : GODREJPROP DATE : 25/03/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENTADVICE: CALLCS CALL:- BUY GODREJPROP IN CASH ABOVE 847 TGT 864 SL 830 RATIONALEFORARRIVINGINVESTMENTADVICE: TECHNICALVIEW: THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor:

9. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.